Chromium Picolinate Shows Greater Benefits In Diabetes Care Than Other Forms Of Chromium

Chromium Picolinate Shows Greater Benefits In Diabetes Care Than Other Forms Of Chromium: "Chromium Picolinate Shows Greater Benefits In Diabetes Care Than Other Forms Of Chromium"

About the Scientific Review

The studies reviewed in this paper were identified from a number of sources, such as PubMed, Science Direct, and a past review of chromium effects on glycemic control. A total of 1,690 subjects, including 1,505 receiving chromium picolinate, participated in these trials. Twelve of the 15 studies were randomized, controlled trials and three were open-label trials. Chromium picolinate dosages ranged from 200--1000 mcg chromium per day, and the duration of the supplementation ranged from one week to 10 months.

Chromium Picolinate for Diabetes

Chromium picolinate, which is sold in combination with the B-vitamin biotin under the brand name of Diachrome® for people with diabetes, is an essential trace mineral that helps to regulate insulin function. The chromium picolinate in Diachrome has been recognized as safe by many of the world's leading government and academic research institutions, including the U.S. Food and Drug Administration, the Institute of Medicine and the UK's Food Standards Agency. In addition, biotin has been deemed safe by the U.S. Food and Drug Administration and is also Generally Recognized as Safe (GRAS) for use in foods and supplements.

###

About Nutrition 21

Nutrition 21 is a nutritional bioscience company and the maker of chromium picolinate-based, selenium and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds 33 patents for nutrition products and uses. The company markets Chromax® chromium picolinate, which is the most-studied form of the essential mineral chromium. Chromax, a supplement for healthy and pre-diabetic people that promotes insulin health and helps improve blood sugar metabolism, cardiovascular disease, control cravings and fight weight gain, is now available through food, drug and mass retailers nationwide. Another chromium picolinate-based supplement developed and marketed by Nutrition 21 is Diachrome®, a proprietary, non-prescription, insulin sensitizer for people with type 2 diabetes. It is sold in select drug retailers nationwide. Nutrition 21 also markets Selenomax®, a high selenium yeast supplement that stimulates and protects the immune system by supporting antibody production and preventing free-radical damage. Selenomax is available at CVS/pharmacy in all its 6,200 retail stores across the country, including PharmaCare Specialty Pharmacy locations. The Company is the exclusive importer of Icelandic fish oils, including omega-3 fatty acids, which are manufactured to pharmaceutical standards and sold under the Iceland Health® brand.

New Blood Glucose Meters, Contour® And Breeze®2, Now Available In Pharmacies Nationwide, USA

New Blood Glucose Meters, Contour® And Breeze®2, Now Available In Pharmacies Nationwide, USA: "New Blood Glucose Meters, Contour® And Breeze®2, Now Available In Pharmacies Nationwide, USA"

Bayer Diabetes Care, a division of Bayer HealthCare LLC and a member of the Bayer Group (NYSE: BAY), announced today the availability of the latest advances in their line of blood glucose meters: the new CONTOUR® and BREEZE®2 meters. As an innovator of meters with No Coding™ technology, Bayer's new meters now offer shorter testing times and easier functionality.

Unlike most meters that need to be manually coded to assure accurate results, CONTOUR and BREEZE2 continue the innovation of previous Bayer meters by automatically setting the correct code any time a Bayer test strip is inserted - so there is less chance for error and fewer steps.

With the new CONTOUR and BREEZE2 blood glucose meters, people with diabetes can now obtain accurate blood glucose test results in just five seconds. The new meters also offer improved test memory to support better diabetes management.

BREEZE2 requires a small blood sample (1µL) size and includes a 10-test disc system, allowing users to test 10 times without handling individual strips, and has received the Ease-of-Use Commendation from the Arthritis Foundation. The new CONTOUR offers automatic features including No Coding™ technology and hematocrit correction, a faster test time, small (0.6 µL) blood sample requirement, meal markers and test reminder alarm.

The new CONTOUR and BREEZE2 blood glucose meters are now available at pharmacies nationwide, or by calling Bayer's free Customer Service Help Line at 1-800-348-8100.

Strong Evidence Links Soft Drink Consumption To Obesity, Diabetes

Strong Evidence Links Soft Drink Consumption To Obesity, Diabetes: "Strong Evidence Article Also Appears In Diabetes Nutrition / Diet


The case against swigging soda just got stronger. A large systematic review reveals clear associations between consumption of nondiet soft drinks and increased calorie intake and body weight.

Full-calorie soft drinks are also linked with reduced intake of milk and fruit and increased risk of type 2 diabetes. 'Recommendations to reduce population soft drink consumption are strongly supported by the available science,' concludes the review of 88 studies.

The American Beverage Association, however, presents a different view on its Web site. 'It is not feasible to blame any one food product or beverage as being a sole contributor to obesity …. No science supports such a claim.'

Carbonated soft drinks are the single largest source of calories in the American diet, according to a 2005 report called 'Liquid Candy,' produced by the nonprofit Center for Science in the Public Interest (CSPI). Companies annually manufacture enough soda pop to provide more than 52 gallons to every man, woman and child in the United States.

'Nobody claims there is a single cause to the obesity problem, but the existing science certainly puts soft drinks in the list of leading contributors,' said review co-author Kelly Brownell, Ph.D. He is director of the Rudd Center for Food Policy and Obesity at Yale University."